Sanofi (SNY) Expected to Announce Earnings of $0.75 Per Share
Wall Street analysts expect Sanofi (NYSE:SNY) to announce earnings of $0.75 per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Sanofi’s earnings. The lowest EPS estimate is $0.72 and the highest is $0.78. Sanofi reported earnings per share of $0.74 during the same quarter last year, which would suggest a positive year-over-year growth rate of 1.4%. The company is expected to issue its next earnings results before the market opens on Monday, July 31st.
According to Zacks, analysts expect that Sanofi will report full-year earnings of $3.20 per share for the current financial year, with EPS estimates ranging from $3.18 to $3.24. For the next financial year, analysts expect that the company will post earnings of $3.36 per share, with EPS estimates ranging from $3.22 to $3.46. Zacks Investment Research’s EPS calculations are a mean average based on a survey of research firms that cover Sanofi.
Sanofi (NYSE:SNY) last released its quarterly earnings results on Friday, April 28th. The company reported $0.76 earnings per share for the quarter, topping analysts’ consensus estimates of $0.73 by $0.03. The business had revenue of $8.65 billion for the quarter, compared to analysts’ expectations of $8.40 billion. Sanofi had a return on equity of 25.89% and a net margin of 26.55%. The company’s quarterly revenue was up 1.2% on a year-over-year basis.
Several equities research analysts recently commented on SNY shares. TheStreet raised Sanofi from a “c+” rating to a “b-” rating in a report on Monday, April 24th. Argus assumed coverage on Sanofi in a report on Thursday, April 6th. They issued a “buy” rating and a $50.00 price target on the stock. Zacks Investment Research raised Sanofi from a “hold” rating to a “buy” rating and set a $50.00 price target on the stock in a report on Tuesday, April 11th. BidaskClub raised Sanofi from a “hold” rating to a “buy” rating in a report on Friday, June 23rd. Finally, Berenberg Bank cut Sanofi from a “buy” rating to a “hold” rating in a report on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. Sanofi presently has a consensus rating of “Hold” and a consensus target price of $67.67.
Several institutional investors have recently bought and sold shares of SNY. Fisher Asset Management LLC boosted its position in Sanofi by 8.1% in the second quarter. Fisher Asset Management LLC now owns 13,638,458 shares of the company’s stock valued at $653,419,000 after buying an additional 1,022,953 shares in the last quarter. Bank of America Corp DE boosted its position in Sanofi by 8.2% in the first quarter. Bank of America Corp DE now owns 7,531,334 shares of the company’s stock valued at $340,792,000 after buying an additional 572,652 shares in the last quarter. Wells Fargo & Company MN boosted its position in Sanofi by 22.2% in the first quarter. Wells Fargo & Company MN now owns 4,492,719 shares of the company’s stock valued at $203,296,000 after buying an additional 815,820 shares in the last quarter. Brandes Investment Partners LP boosted its position in Sanofi by 3.0% in the first quarter. Brandes Investment Partners LP now owns 3,490,226 shares of the company’s stock valued at $157,933,000 after buying an additional 102,511 shares in the last quarter. Finally, Hamlin Capital Management LLC boosted its position in Sanofi by 11.8% in the first quarter. Hamlin Capital Management LLC now owns 1,768,523 shares of the company’s stock valued at $80,026,000 after buying an additional 186,280 shares in the last quarter. Institutional investors and hedge funds own 9.84% of the company’s stock.
Shares of Sanofi (NYSE:SNY) opened at 48.06 on Friday. The firm has a market cap of $121.37 billion, a PE ratio of 11.65 and a beta of 0.89. Sanofi has a 12-month low of $36.81 and a 12-month high of $50.24. The company has a 50 day moving average price of $48.37 and a 200-day moving average price of $45.39.
ILLEGAL ACTIVITY WARNING: “Sanofi (SNY) Expected to Announce Earnings of $0.75 Per Share” was originally published by American Banking News and is owned by of American Banking News. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/07/21/sanofi-sny-expected-to-announce-earnings-of-0-75-per-share.html.
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. The Company’s segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.